Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Splenectomy for hematologic disease. Mini-invasive versus traditional technique].

E Monteferrante1, A Giunta, L Bigi

  • 1Divisione di Chirurgia Generale U.O. II, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.

Minerva Chirurgica
|June 26, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carbon sequestration potential of high-altitude afforestation in the Eastern Central Alps.

Journal of environmental management·2026
Same author

Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis).

The Journal of dermatological treatment·2024
Same author

PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study.

Expert opinion on biological therapy·2023
Same author

Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

A single-centre, observational, retrospective, real-life study evaluating adalimumab biosimilar ABP 501 in the treatment of plaque-type psoriasis and psoriatic arthritis in originator-naïve patients and in patients undergoing non-medical switch from originator.

Current medical research and opinion·2021

Laparoscopic splenectomy (LS) is as safe and effective as open splenectomy (OS) for hematologic disorders, offering a shorter hospital stay. This makes LS the preferred surgical approach for these conditions.

Area of Science:

  • Surgical Oncology
  • Minimally Invasive Surgery
  • Hematology

Background:

  • Hematologic disorders often necessitate splenectomy.
  • Comparing laparoscopic splenectomy (LS) and open splenectomy (OS) is crucial for patient outcomes.

Purpose of the Study:

  • To compare the safety, efficacy, and clinical benefits of LS versus OS.
  • To evaluate perioperative characteristics, outcomes, complications, and costs.

Main Methods:

  • A prospective study involving 48 adult patients undergoing splenectomy.
  • 30 patients underwent LS, and 18 underwent OS.
  • Comparative analysis of perioperative data, outcomes, and complications.

Main Results:

  • LS demonstrated a shorter mean postsurgical stay (5.8 days) compared to OS (8.5 days).

Related Experiment Videos

  • Complication rates were lower in the LS group (3 patients) than in the OS group (5 patients).
  • Efficacy and response rates were similar between LS and OS groups.

    • Conclusions:

    • Laparoscopic splenectomy (LS) is a safe and effective alternative to open splenectomy (OS).
    • LS is associated with a significantly shorter hospital stay.
    • LS should be considered the technique of choice for intractable benign hematologic diseases.